Choate, Radmila http://orcid.org/0000-0002-0540-8377
Holm, Kristen E. http://orcid.org/0000-0003-2280-2322
Sandhaus, Robert A. http://orcid.org/0000-0002-7937-2485
Mannino, David M. http://orcid.org/0000-0003-3646-7828
Strange, Charlie http://orcid.org/0000-0002-8109-8067
Funding for this research was provided by:
AlphaNet
Article History
Received: 11 January 2024
Accepted: 5 March 2024
First Online: 18 March 2024
Declarations
:
: The study analyses were conducted under the approval of the University of Kentucky Institutional Review Board (#43435) with a waiver of informed consent due to the retrospective analysis of existing data.
: Not applicable.
: RC has received research support from AlphaNet. KEH has received consulting income from AlphaNet. RAS is an employee of AlphaNet. DMM is a consultant to GlaxoSmithKline, AstraZeneca, Regeneron, Genentech, Up to Date, and the COPD Foundation. CS has grants in alpha-1 antitrypsin deficiency paid to the Medical University of South Carolina from Adverum, Arrowhead, Grifols, Krystal, Mereo, NIH, Takeda and Vertex within the past 3 years. He is a salaried medical director at AlphaNet. He has consulted for CSL Behring, Dicerna, Grifols, and Vertex for Alpha-1.